The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC): A phase III study utilizing the German Registry of Incidental Gallbladder Carcinoma Platform (GR)—The AIO/CALGP/ACO-GAIN-Trial.
 
Thorsten Oliver Goetze
Consulting or Advisory Role - Bayer; Lilly; MSD Oncology; Roche; SERVIER
Speakers' Bureau - Lilly
Research Funding - Deutsche Forschungsgemeinschaft; Gemeinsamer Bundesausschuss
 
Ulli Simone Bankstahl
No Relationships to Disclose
 
Sven A. Lang
No Relationships to Disclose
 
Steffen Heeg
No Relationships to Disclose
 
Wolf Otto Bechstein
Honoraria - Astellas Pharma; Baxter; Chiesi; Integra LifeSciences; MCI Group; MCI Group; Medupdate; Merck Serono; Teva
Consulting or Advisory Role - Astellas Pharma; Novartis
Speakers' Bureau - Integra LifeSciences
Travel, Accommodations, Expenses - Astellas Pharma; Baxter; Chiesi; Integra LifeSciences; MCI Deutschland; Medupdate; Merck Serono; Novartis; Teva
 
Andreas Schnitzbauer
No Relationships to Disclose
 
Ursula Pession
No Relationships to Disclose
 
Daniel Reim
Travel, Accommodations, Expenses - Takeda
 
Sylvie Lorenzen
No Relationships to Disclose
 
Tobias Keck
No Relationships to Disclose
 
Alfred Königsrainer
Honoraria - Capnomed
Consulting or Advisory Role - Medtronic
Travel, Accommodations, Expenses - Capnomed; Medtronic
 
Pompiliu Piso
No Relationships to Disclose
 
Arndt Vogel
Honoraria - Amgen; Bristol-Myers Squibb; Delcath Systems; Ipsen; Janssen; Lilly; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Consulting or Advisory Role - Amgen; AstraZeneca; Baxalta; Bayer; BTG; Eisai; IPSEN; Lilly; Novartis; Pierre Fabre; Roche
Research Funding - Novartis
Travel, Accommodations, Expenses - Bayer; Ipsen; Roche
 
Claudia Pauligk
No Relationships to Disclose
 
Salah-Eddin Al-Batran
Stock and Other Ownership Interests - IKF Klinische Krebsforschung
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Lilly; Merck; Merck Sharp & Dohme; Nordic Bioscience; Roche
Speakers' Bureau - AIO gGmbH; Celgene; Forum für Medizinische Fortbildung; Lilly; MCI group; Nordic Bioscience
Research Funding - Celgene; Federal Ministry of Education and Research; German Cancer Aid; German Research Foundation; Hospira; Lilly; Medac; Merck; Roche; Sanofi; Vifor Pharma